Ascendis Pharma A/S Oncology program update Transcript - Thomson StreetEvents

Ascendis Pharma A/S Oncology program update Transcript

Ascendis Pharma A/S Oncology program update Transcript - Thomson StreetEvents
Ascendis Pharma A/S Oncology program update Transcript
Published May 31, 2023
25 pages (19717 words) — Published May 31, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ASND.OQ conference call or presentation 31-May-23 2:00pm GMT

  
Brief Excerpt:

...Thank you, Scott. It is actually a pleasure to be Back in New York. This is my first really exposure to (inaudible) since COVID. And I feel really pleasure to meet new people, see people coming here and getting breakfast. So it's really, really nice. But I would like to start where I'll always start our Vision 3x3, which is our strategic road map from 2020 to '25, how we want to build a leading global biopharma company. And I would just spend 3, 4 minutes to give you an update how we are focusing to fulfill this vision. TransCon Growth Hormone for pediatric growth hormone deficiency got approved in 2021. Now in the -- being commercialized here in the U.S. under the name SKYTROFA, really building up to be the leading brand in value. We do the commercialization of SKYTROFA in Europe, where we will start to do that in Q3. TransCon PTH is for adult hypoparathyroidism, we are filing our response for -- related to our Type A, meeting with FDA here in June. And in Europe, we are progressing with...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Ascendis Pharma A/S
Ticker
ASND.OQ
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Ascendis Pharma A/S Q3 2023 Earnings Call Transcript – 2023-11-07 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 7-Nov-23 9:30pm GMT

Ascendis Pharma A/S at Morgan Stanley Global Healthcare Conference Transcript – 2023-09-12 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 12-Sep-23 4:55pm GMT

Ascendis Pharma A/S at Citi BioPharma Conference Transcript – 2023-09-07 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 7-Sep-23 6:40pm GMT

Ascendis Pharma A/S Q2 2023 Earnings Call Transcript – 2023-09-05 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 5-Sep-23 8:30pm GMT

Ascendis Pharma A/S at Goldman Sachs Healthcare Conference Transcript – 2023-06-13 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 13-Jun-23 4:20pm GMT

Ascendis Pharma A/S at Bank of America Global Healthcare Conference Transcript – 2023-05-09 – US$ 54.00 – Edited Transcript of ASND.OQ presentation 9-May-23 3:40pm GMT

Ascendis Pharma A/S Regulatory Update Transcript – 2023-05-01 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 1-May-23 12:30pm GMT

Ascendis Pharma A/S Q1 2023 Earnings Call Transcript – 2023-04-27 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 27-Apr-23 8:30pm GMT

Ascendis Pharma A/S Corporate Call Transcript – 2023-04-03 – US$ 54.00 – Edited Transcript of ASND.OQ conference call or presentation 3-Apr-23 12:30pm GMT

Ascendis Pharma A/S Q4 2022 Earnings Call Transcript – 2023-02-16 – US$ 54.00 – Edited Transcript of ASND.OQ earnings conference call or presentation 16-Feb-23 9:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Ascendis Pharma A/S Oncology program update Transcript" May 31, 2023. Alacra Store. May 03, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-Oncology-program-update-T15612835>
  
APA:
Thomson StreetEvents. (2023). Ascendis Pharma A/S Oncology program update Transcript May 31, 2023. New York, NY: Alacra Store. Retrieved May 03, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Ascendis-Pharma-A-S-Oncology-program-update-T15612835>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.